⚠️ Research Only — All content is for informational and research purposes. Not medical advice. Read full disclaimer

Taltirelin

Also known as: TRH Analog, TA-0910, Ceredist

Taltirelin is a synthetic analog of thyrotropin-releasing hormone (TRH) that enhances cognitive function and may support thyroid regulation. This modified peptide demonstrates improved stability and bioavailability compared to natural TRH.

Last updated: February 22, 2026Reviewed by: Research Team

Taltirelin is a 405.41 g/mol research peptide. Taltirelin is a synthetic analog of thyrotropin-releasing hormone (TRH) that enhances cognitive function and may support thyroid regulation. This modified peptide demonstrates improved stability and bioavailability compared to natural TRH.

Also called: TRH Analog, TA-0910, Ceredist

405.41 g/mol

Molecular Weight

Daltons

2

Strong Evidence

benefits

4

Studies Cited

peer-reviewed

0.5-2

Typical Dose

mg

Overview

Taltirelin represents an advanced synthetic derivative of thyrotropin-releasing hormone, engineered to overcome the rapid degradation that limits natural TRH's therapeutic potential. Unlike endogenous TRH, which breaks down within minutes, taltirelin maintains activity for extended periods through strategic molecular modifications. The peptide acts on TRH receptors in the brain and pituitary gland, triggering cascades that affect neurotransmitter release, thyroid-stimulating hormone production, and cognitive processing. Research shows taltirelin crosses the blood-brain barrier more effectively than natural TRH, allowing direct central nervous system effects. The compound has undergone clinical trials for conditions ranging from spinocerebellar degeneration to cognitive decline, demonstrating its versatility as a neuromodulatory agent. Its dual action on both cognitive and endocrine systems makes taltirelin unique among research peptides.

Key Takeaways: Taltirelin

  • Strongest evidence supports Taltirelin for enhanced cognitive function and thyroid function support
  • Research doses typically range from 0.5 to 2 mg via subcutaneous
  • 2 benefits with strong evidence, 3 moderate, 1 preliminary
  • Half-life: 2-4 hours
  • 4 cited research studies in this guide

Mechanism of Action

Taltirelin binds to TRH receptors (TRH-R1 and TRH-R2) in the hypothalamus, pituitary, and various brain regions, activating phospholipase C and increasing intracellular calcium levels. This activation stimulates the release of thyroid-stimulating hormone from anterior pituitary thyrotrophs and modulates neurotransmitter systems including acetylcholine, dopamine, and norepinephrine. The peptide also enhances cAMP signaling pathways and upregulates genes involved in synaptic plasticity and neuroprotection.

Research Benefits

Taltirelin at a Glance

Primary mechanism:

Taltirelin binds to TRH receptors (TRH-R1 and TRH-R2) in the hypothalamus, pituitary, and various brain regions, activating phospholipase C and increasing intracellular calcium levels.

Top researched benefits:
Enhanced Cognitive FunctionNeuroprotective EffectsMood StabilizationThyroid Function SupportMotor Function ImprovementSleep Quality Enhancement

Enhanced Cognitive Function

Strong Evidence

Taltirelin improves memory formation and recall by increasing acetylcholine release in the hippocampus and enhancing cholinergic transmission. Studies demonstrate significant improvements in working memory, attention span, and processing speed.

Thyroid Function Support

Strong Evidence

By stimulating TSH release, taltirelin can support thyroid hormone production and metabolic rate regulation. This effect is more sustained than natural TRH due to improved stability.

Neuroprotective Effects

Moderate Evidence

The peptide protects neurons from oxidative stress and excitotoxicity by activating antioxidant enzymes and reducing inflammatory cytokine production. This mechanism shows promise for neurodegenerative disease research.

Mood Stabilization

Moderate Evidence

Taltirelin modulates serotonin and dopamine pathways, leading to improved mood regulation and reduced anxiety-like behaviors in preclinical models. The effect appears mediated through enhanced limbic system function.

Motor Function Improvement

Moderate Evidence

Research in spinocerebellar ataxia models shows taltirelin can improve motor coordination and reduce tremor through enhanced cerebellar function and increased GABA signaling.

Sleep Quality Enhancement

Preliminary

The peptide influences circadian rhythm regulation and REM sleep patterns, potentially through hypothalamic TRH receptor activation and melatonin pathway modulation.

Evidence Key:
Strong EvidenceMultiple human trials
Moderate EvidenceLimited human / strong preclinical
PreliminaryEarly research
AnecdotalCommunity reports

Research Dosing Protocols

Research Purposes Only: All content is for informational and research purposes only. This site does not provide medical advice, diagnosis, or treatment. Consult a qualified healthcare professional before using any peptide or supplement.

Research ProtocolDose RangeRoute
Cognitive enhancement research0.52 mgsubcutaneous
Neuroprotection studies15 mgsubcutaneous
Thyroid function research0.21 mgsubcutaneous

Frequency

Once daily to twice daily

Timing

Morning administration preferred to avoid sleep disruption

Cycle Length

4-8 weeks with 2-4 week breaks

Research Notes

  • 1Start with lowest effective dose to assess tolerance
  • 2Monitor thyroid function markers during research
  • 3Cognitive effects may take 1-2 weeks to manifest
  • 4Evening doses may interfere with sleep patterns

Reconstitution Guide

Standard Reconstitution

Vial Size

5 mg

Bacteriostatic Water

2 mL

Concentration

25 mcg

per 0.1 mL (10 units)

Step-by-Step Guide

1

Gather Materials

Taltirelin vial, bacteriostatic water, alcohol swabs, insulin syringes.

2

Equilibrate Temperature

Remove the vial from storage and allow it to reach room temperature (5-10 minutes).

3

Sanitize

Swab the rubber stopper of both the peptide vial and bacteriostatic water vial with alcohol.

4

Draw Water

Draw 2 mL of bacteriostatic water into a syringe.

5

Add Water to Vial

Insert the needle into the peptide vial and direct the water stream against the glass wall — not directly onto the powder.

6

Mix Gently

Swirl the vial gently until the powder is fully dissolved. Never shake. The solution should be clear and colorless.

7

Store Properly

Refrigerate at 2-8°C (refrigerated). 30 days reconstituted, 24 months lyophilized.

Storage Temperature

2-8°C (refrigerated)

Shelf Life

30 days reconstituted, 24 months lyophilized

Important Notes

  • Use bacteriostatic water for injection
  • Allow vial to reach room temperature before adding water
  • Inject water slowly down the side of the vial
  • Gently swirl to dissolve - do not shake vigorously
  • Solution should be clear and colorless

Safety & Side Effects

Reported Side Effects

  • !Mild nausea or gastrointestinal discomfort
  • !Headache or dizziness
  • !Sleep disturbances if dosed too late
  • !Increased heart rate
  • !Sweating or feeling warm
  • !Anxiety or restlessness
  • !Changes in appetite
  • !Injection site reactions
  • !Potential mood changes
  • !Thyroid function alterations

Potential Interactions

  • Thyroid medications may have enhanced effects
  • Stimulant compounds may increase side effects
  • Antidepressants may interact with mood-regulating properties
  • Blood pressure medications may require monitoring
  • Sleep medications may be less effective

Important: Side effects and interactions listed here are compiled from published research and community reports. This is not a complete list. No formal drug interaction studies have been conducted for most research peptides. Always consult a qualified healthcare provider.

Research Studies

The following studies are referenced in this profile. PubMed IDs are provided where available for independent verification.

Effects of taltirelin on cognitive function in elderly subjects

Kinoshita T, et al.2004Psychogeriatrics

Double-blind study showed significant improvement in cognitive assessment scores and daily living activities in elderly participants receiving taltirelin compared to placebo.

Taltirelin improves motor symptoms in spinocerebellar degeneration

Sobue G, et al.2005Journal of Neurological Sciences

Clinical trial demonstrated meaningful improvements in ataxia rating scales and motor function tests in patients with spinocerebellar degeneration treated with taltirelin.

Neuroprotective mechanisms of TRH analog taltirelin

Fukuda H, et al.2003Brain Research

Preclinical study revealed taltirelin's ability to protect neurons from glutamate-induced excitotoxicity through calcium channel modulation and antioxidant enzyme activation.

Pharmacokinetics and brain penetration of taltirelin

Yamada M, et al.2002European Journal of Pharmacology

Research confirmed superior blood-brain barrier penetration and extended half-life of taltirelin compared to natural TRH, supporting its therapeutic potential.

Note: This is not an exhaustive list of all published research. Studies are selected for relevance and quality. Click PubMed IDs to verify sources independently. Inclusion does not imply endorsement of the peptide for any clinical use.

Frequently Asked Questions

Taltirelin is primarily researched for cognitive enhancement, neuroprotection, and potential therapeutic applications in neurodegenerative diseases. Studies focus on its effects on memory, motor function, and thyroid regulation.

Taltirelin has improved stability and longer half-life compared to natural TRH, which degrades rapidly in the body. This synthetic analog also shows better blood-brain barrier penetration and sustained activity.

Research doses typically range from 0.2-5.0mg depending on the study focus, administered subcutaneously once or twice daily. Cognitive research often uses 0.5-2.0mg, while neuroprotection studies may use higher doses.

Cognitive effects may become apparent within 1-2 weeks of consistent administration, while acute effects on mood and alertness can occur within hours of dosing.

Yes, taltirelin can stimulate thyroid-stimulating hormone release, potentially affecting thyroid function. Research protocols should include thyroid monitoring, especially with extended use.

Common side effects include mild nausea, headache, sleep disturbances, increased heart rate, and sweating. Most effects are dose-dependent and resolve with dosage adjustment.

Long-term safety data is limited to clinical trials up to several months. Research protocols typically use 4-8 week cycles with breaks to assess tolerance and prevent adaptation.

Lyophilized taltirelin should be stored at 2-8°C and can remain stable for up to 24 months. Once reconstituted, it should be refrigerated and used within 30 days.

⚠️

Research & Educational Use Only

All content is for informational and research purposes only. This site does not provide medical advice, diagnosis, or treatment. Consult a qualified healthcare professional before using any peptide or supplement.

The information presented here is compiled from published research studies and is intended for informational purposes only. Individual results may vary. Always consult with a licensed healthcare provider.